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The results of the 1995 Managed Care Survey of the ACC
membership are published in this issue of the Journal (1). This
survey conﬁrms the ﬁndings of the original survey of 1993 (2).
A large majority of the membership are involved with managed
care and have adjusted their practices by merging, networking,
installing clinical pathways and instituting continuous quality
improvement programs. It is clear that most do not like
managed care, particularly the limitations on access to cardio-
vascular specialists and other restrictions, which are perceived
to reduce the quality of care (and raise ethical dilemmas).
There is a strong sentiment that physicians must now proac-
tively respond to these changes.
The United States spends more on its health care system
than any other nation ($1 trillion). Unlike other nations,
one-half of our system is not directly funded by the govern-
ment. It appears that we have enough doctors and facilities to
provide optimal care, although they are not optimally distrib-
uted or universally available. Since 1960, health care costs have
consistently exceeded the rate of inﬂation. By the 1970s, the
private sector was embracing the managed care concept,
concluding that the fee-for-service system needed to be altered
to eliminate incentives to provide “more” care.
The growth of the managed care industry in the past 10
years has been truly remarkable. Extensive mergers and acqui-
sitions have been allowed by the government (shades of the
1890s?), while attempts by physician groups to organize have
been suppressed by rules from the Federal Trade Commission.
Obtaining the lowest cost, regardless of quality (even when
quality measures are available) has been the driving force of
managed care up to now. Physicians, as well as other health
professionals who viewed this with alarm, were ignored. Only
recently has evidence appeared that a strictly cost-based health
care system produces bad outcomes (3,4). This is especially
true for patients with chronic cardiovascular disease and
patients on Medicare.
Despite claims to the contrary, managed care by both
private insurers and Medicare has not slowed the growth of
total health care costs. Indeed, the inexorable increase in
health care costs is a worldwide problem, reﬂecting new
technology for diagnosis and therapy, a high percentage of
costs due to health care worker salaries (more than half the
total cost) and the successful application of new technology to
the older population.
The failure to control costs is also related to a major
characteristic of medicine, that of “marginal decisions,” which
is poorly understood by business (5). Marginal decisions, in an
economic sense, are those for which there is little clear
scientiﬁc basis and are thus very difﬁcult to make (and no one
wants to make them). As doctors, we make these decisions
every day (we call this “clinical judgment”), and this process
has proved hard for managed care to control.
Despite the tremendous growth of the managed care indus-
try, it is still very much a work in progress (6). The optimal
arrangement among physicians, their patients and payers is still
not clear. The dominant model today (i.e., for-proﬁt managed
care) may not be so in 5 to 10 years. Furthermore, as Ginsberg
(7) points out, the “market solution” applies only to one-half of
the health care system. The majority of hospitals are nonproﬁt,
with a mission for charity care. The competitive market cannot
provide for the poor or change the public’s bad health habits.
Thus, eventually health system reform requires that the inter-
ests of both the private and public sectors be addressed.
In the past year, two important changes have occurred that
will be helpful for the preservation of high quality cardiovas-
cular care. First, our patients have called Congress, the man-
aged care industry and the media about the adverse effects of
restricting specialty care. As a result, Congress, the President
and many business leaders now accept this concept. Second,
the Federal Trade Commission released new rules that make it
far easier for physician-led networks to enter the market and
compete on quality (as well as cost). Until now, physicians have
been largely excluded from planning health care system
change, but their inclusion now appears possible.
Cardiovascular medicine is a critical component of planning
for the health care system of the future because cardiovascular
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disease will be even more prevalent as a cause of morbidity and
mortality by the year 2010. Indeed, some project a shortage of
cardiovascular specialists at that time, particularly as the
number of current trainees continues to decline (8,9). Our
specialty is particularly well positioned to participate in the
development of the new health care system because we have
well established, cost-effective disease management strategies
for nearly all types of heart disease (prevention, ischemic heart
disease, valvular disease, congestive heart failure, arrhythmias,
hypertension).
Rather than accepting a “dumbed down” purely cost-
control reform strategy, we need to advocate a system in which
quality at a good price (value) is the objective. This means that
cardiovascular specialists ﬁrst must eliminate the unnecessary
costs that we generate. We have already done much in this
arena. Economic efﬁciency in caring for patients in the hospital
has doubled in the past 10 years (sicker patients cared for in
half the time at half the professional fee). There has been
continuous improvement in the efﬁciency of our laboratory
procedures. Unfortunately, new technology (usually with a
better outcome) has obscured this. But we can do better, and
we must develop strategies using our ACC/AHA guidelines to
further decrease costs without compromising care.
As quality and value rather than cost control become the
paradigm for the new system, cardiovascular specialists, with
leadership from the American College of Cardiology, can
proactively enter the health care system reform debate. The
ACC/AHA practice guidelines are a critical component of this
effort because these guidelines are nationally accepted as
advocating the highest quality care. However, the guidelines
need to be kept current, to be expanded and, most important,
made more user friendly. The College must collaborate with
the government, business, managed care and other interested
physician groups to accept the guidelines and develop methods
to implement them in daily practice. This will require new
approaches, which were extensively discussed at the October
Bethesda Conference on Practice Guidelines and the Quality
of Care.
The ACC data base has been substantially altered to
provide a meaningful and unbiased national benchmark. All of
us must participate to provide information on the state of the
practice of cardiovascular medicine. This outcome data base is
far superior to charge-based data bases widely used by govern-
ment and managed care. Our data base will help us to develop
data-driven guidelines. Methods are being explored to com-
bine guidelines and other evidence-based medicine into
computer-based systems that simultaneously provide outcome
data to our data base and recommendations for and documen-
tation of clinical care.
A better understanding of cost-effectiveness and other
economic concepts is essential to the development of new
practice guidelines. The ACC economic summit, planned for
February 1997, will be a start, and it will then be possible to
incorporate this knowledge into our various CME programs,
and, most important, our practice guidelines.
In the managed care setting, patients must assume more
responsibility for their own care. This requires more effective
patient education, which will be feasible once the ACC Web
site is underway.
There is one vitally important caveat with regard to the
implementation of the ACC/AHA clinical practice guidelines.
The guidelines, in reality, are only a matrix for experienced
players. They assume considerable knowledge of cardiovascu-
lar medicine as well as clinical experience in caring for patients
with cardiovascular disease. There are still many class II
indications that require that marginal decisions be made. In
one sense, guidelines make decision making easier by provid-
ing expert consensus opinion, but, paradoxically, their very
presence increases the complexity of the decision making.
Thus, we must be sure there are adequate numbers of clinical
cardiologists available to care for the increased number of
patients in the future, especially because only half of such
patients are currently seen by a cardiologist.
In the traditional fee-for-service system, the major problem
was too much care. In the new paradigm, it will be too little
care. Thus, as part of the College’s role to advocate optimal
quality and value, it must also speak out about too little care
when such exists.
Einstein once noted that in the middle of every difﬁculty
there lies an opportunity. The current system is in a state of
ﬂux. The time is now for cardiovascular specialists, with the
leadership of the ACC, to actively participate in the develop-
ment of a new health care system, where quality care, value
and accountability are the major features. If we are successful,
I foresee that organized physician and payer groups will
eventually develop quality patient care systems by direct
negotiation, with insurers once again serving only as under-
writers.
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